Published in J Virol on September 09, 2009
Host factors involved in hepatitis B virus maturation, assembly, and egress. Med Microbiol Immunol (2012) 1.06
Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses. J Virol (2014) 0.90
Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis. J Virol (2012) 0.84
Murine norovirus protein NS1/2 aspartate to glutamate mutation, sufficient for persistence, reorients side chain of surface exposed tryptophan within a novel structured domain. Proteins (2013) 0.83
Hepatitis B virus surface antigen assembly function persists when entire transmembrane domains 1 and 3 are replaced by a heterologous transmembrane sequence. J Virol (2010) 0.82
MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects. World J Gastroenterol (2014) 0.81
Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine. PLoS One (2012) 0.81
Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region. J Virol (2013) 0.81
Assembly and Release of Hepatitis B Virus. Cold Spring Harb Perspect Med (2015) 0.79
A Review of Functional Motifs Utilized by Viruses. Proteomes (2016) 0.77
Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A (2002) 4.52
Topology prediction for helical transmembrane proteins at 86% accuracy. Protein Sci (1996) 4.50
The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A (1991) 4.37
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A (1980) 3.97
Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science (1986) 3.01
Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide. Mol Cell Biol (1986) 2.69
Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol (1992) 2.45
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24
Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen. Mol Cell Biol (1987) 2.18
Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J Virol (1999) 2.09
Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol (2007) 2.07
Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J (1995) 2.05
Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol Cell Biol (1989) 2.05
Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology (1993) 1.95
Hepatitis B virus morphogenesis. World J Gastroenterol (2007) 1.92
A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol (1997) 1.78
Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology (1995) 1.77
Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology (1993) 1.75
Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol (1994) 1.73
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology (2007) 1.71
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol (2008) 1.70
The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences. J Virol (1990) 1.68
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol (2005) 1.68
Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol (2003) 1.65
Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol (1987) 1.64
NORSp: Predictions of long regions without regular secondary structure. Nucleic Acids Res (2003) 1.58
Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol (1998) 1.57
Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol (1991) 1.56
Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol (1995) 1.54
Hepatitis B virus morphogenesis. Curr Top Microbiol Immunol (1996) 1.52
Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol (2001) 1.52
Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation. J Biol Chem (2001) 1.43
Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol (2007) 1.43
A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus. J Virol (2001) 1.38
Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle. Virology (1997) 1.36
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol (2007) 1.33
Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology (1996) 1.33
Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology (2006) 1.26
A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol (2009) 1.24
Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol (1996) 1.20
Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J Virol (2005) 1.16
Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol (2007) 1.16
Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression. J Virol (2006) 1.10
Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol (2006) 1.05
Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein. J Gen Virol (1995) 1.05
Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J Virol (1992) 1.01
A metastable form of the large envelope protein of duck hepatitis B virus: low-pH release results in a transition to a hydrophobic, potentially fusogenic conformation. J Virol (2000) 0.93
Replicating and virion secreting hepatitis B mutant virus unable to produce preS2 protein. J Hepatol (1991) 0.93
A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome. J Virol (2005) 0.92
Future prospectives for the management of chronic hepatitis B. World J Gastroenterol (2007) 0.91
Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus. Virus Res (2000) 0.89
Prediction of a putative fusion peptide in the S protein of hepatitis B virus. J Gen Virol (1994) 0.84
The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity. J Virol (2007) 0.81
Structural properties of the putative fusion peptide of hepatitis B virus upon interaction with phospholipids. Circular dichroism and Fourier-transform infrared spectroscopy studies. Eur J Biochem (1996) 0.79
Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A (2002) 4.52
Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol (2007) 1.95
Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J (2009) 1.90
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology (2007) 1.71
Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol (2005) 1.32
The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem (2003) 1.26
Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology (2006) 1.26
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology (2007) 1.23
Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol (2002) 1.21
A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation. Cell Microbiol (2008) 1.10
The naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathway. PLoS Biol (2011) 1.08
Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J Biol Chem (2009) 0.95
Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur J Pharm Sci (2006) 0.94
Multiple division cycles and long-term survival of hepatocytes are distinctly regulated by extracellular signal-regulated kinases ERK1 and ERK2. Hepatology (2009) 0.92
Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos (2007) 0.89
The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity. J Virol (2007) 0.81
Hepatocyte iron loading capacity is associated with differentiation and repression of motility in the HepaRG cell line. Genomics (2005) 0.79
In vitro and ex vivo permissivity of hepatocytes for Leishmania donovani. J Eukaryot Microbiol (2005) 0.77
Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA of the hepatitis C virus. Bioorg Med Chem Lett (2009) 0.77
The complexity of ERK1 and ERK2 MAPKs in multiple hepatocyte fate responses. J Cell Physiol (2012) 0.76
Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle. FEBS J (2007) 0.75